Literature DB >> 19386814

Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans.

Stephen P Hoole1, Sadia N Khan, Paul A White, Patrick M Heck, Rajesh K Kharbanda, Cameron G Densem, Sarah C Clarke, Leonard M Shapiro, Peter M Schofield, Michael O'Sullivan, David P Dutka.   

Abstract

AIMS: Remote ischaemic pre-conditioning (RIPC) reduces distant tissue ischaemia reperfusion injury. We tested the hypothesis that RIPC would protect the left ventricle (LV) from ischaemic dysfunction and stunning. METHODS AND
RESULTS: Forty-two patients with single vessel coronary disease and normal LV function were prospectively recruited. Twenty patients had repeated conductance catheter assessment of LV function during serial coronary occlusions with/without RIPC and a further 22 patients underwent serial dobutamine stress echocardiography and tissue Doppler analysis with/without RIPC. Remote ischaemic pre-conditioning was induced by three 5 min inflations of a blood pressure cuff around the upper arm. RIPC did not diminish the degree of ischaemic LV dysfunction during coronary balloon occlusion (Tau, ms: 59.2 (2.8) vs. 62.8 (2.8), P = 0.15) and there was evidence of cumulative LV dysfunction despite RIPC [ejection fraction (EF), %: 54.3 (5.8) vs. 44.9 (3.7), P = 0.03]. Remote ischaemic pre-conditioning did not improve contractile recovery during reperfusion (EF, %: 51.7 (3.6) vs. 51.5 (5.7), P = 0.88 and Tau, ms: 55.6 (2.8) vs. 56.0 (2.0), P = 0.85). A neutral effect of RIPC on LV function was confirmed by tissue Doppler analysis of ischaemic segments at peak dobutamine (V(s), cm s(-1) control: 8.2 (0.4) vs. RIPC 8.1 (0.4), P = 0.43) and in recovery.
CONCLUSION: RIPC does not attenuate ischaemic LV dysfunction in humans.

Entities:  

Mesh:

Year:  2009        PMID: 19386814     DOI: 10.1093/eurjhf/hfp040

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  9 in total

1.  Remote preconditioning in normal and hypertrophic rat hearts.

Authors:  Christos Voucharas; Antigoni Lazou; Filippos Triposkiadis; Nikolaos Tsilimingas
Journal:  J Cardiothorac Surg       Date:  2011-03-23       Impact factor: 1.637

2.  Clinical applications of remote ischemic preconditioning.

Authors:  Kristin Veighey; Raymond J Macallister
Journal:  Cardiol Res Pract       Date:  2012-02-14       Impact factor: 1.866

3.  Remote ischemic conditioning: a promising therapeutic intervention for multi-organ protection.

Authors:  Da Zhou; Jiayue Ding; Jingyuan Ya; Liqun Pan; Yuan Wang; Xunming Ji; Ran Meng
Journal:  Aging (Albany NY)       Date:  2018-08-16       Impact factor: 5.682

Review 4.  Circulating mediators of remote ischemic preconditioning: search for the missing link between non-lethal ischemia and cardioprotection.

Authors:  Muntasir Billah; Anisyah Ridiandries; Usaid Allahwala; Harshini Mudaliar; Anthony Dona; Stephen Hunyor; Levon M Khachigian; Ravinay Bhindi
Journal:  Oncotarget       Date:  2019-01-04

Review 5.  Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis.

Authors:  Daniel Brevoord; Peter Kranke; Marijn Kuijpers; Nina Weber; Markus Hollmann; Benedikt Preckel
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

Review 6.  The role of remote ischemic preconditioning in the treatment of atherosclerotic diseases.

Authors:  Spyros N Vasdekis; Dimitrios Athanasiadis; Andreas Lazaris; Georgios Martikos; Aristeidis H Katsanos; Georgios Tsivgoulis; Anastasios Machairas; Theodoros Liakakos
Journal:  Brain Behav       Date:  2013-08-30       Impact factor: 2.708

7.  Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.

Authors:  Joel P Giblett; Richard G Axell; Paul A White; Sophie J Clarke; Liam McCormick; Philip A Read; Johannes Reinhold; Adam J Brown; Michael O'Sullivan; Nick E J West; David P Dutka; Stephen P Hoole
Journal:  Cardiovasc Diabetol       Date:  2016-07-19       Impact factor: 9.951

8.  Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Coronary Artery Bypass Grafting Undergoing: A Randomized Clinical Trial.

Authors:  Ali Karami; Mohamad Bagher Khosravi; Masih Shafa; Simin Azemati; Saeed Khademi; Seyed Hedayatalla Akhlagh; Behzad Maghsodi
Journal:  Iran J Med Sci       Date:  2016-07

Review 9.  Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia.

Authors:  Joel P Giblett; Sophie J Clarke; David P Dutka; Stephen P Hoole
Journal:  JACC Basic Transl Sci       Date:  2016-06-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.